- 54605-72-01H-Pyrazole-4-carboxaldehyde,1-phenyl-
- 54606-49-41-Pyrrolidinyloxy,3-(aminomethyl)-2,2,5,5-tetramethyl-
- 5460-79-74-Piperidinecarbonitrile,4-(3-methoxyphenyl)-1-methyl-
- 54608-96-73-(4-nitrophenyl)-5-thiophen-2-yl-1,2,4-oxadiazole
- 54609-09-5Phenol, 4-(2,5-dimethyl-1H-pyrrol-1-yl)-
- 54610-69-42-Furancarboximidamide,hydrochloride (1:1)
- 54610-70-72-Thiophenecarboximidamide,hydrochloride (1:1)
- 5461-08-5Propanoic acid,2-methyl-, 1,3-benzodioxol-5-ylmethyl ester
- 5461-32-5Benzenepropanoic acid,2-nitro-a-oxo-
- 54613-99-9N-Boc-N'-(2-chlorobenzyloxycarbonyl)-L-lysine
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
| Name |
Iocarmate meglumine |
EINECS | N/A |
| CAS No. | 54605-45-7 | Density | N/A |
| PSA | 431.32000 | LogP | 2.08120 |
| Solubility | N/A | Melting Point |
N/A |
| Formula | C24H20I6N4O8•2C7H17NO5 | Boiling Point | N/A |
| Molecular Weight | 1644.38 | Flash Point | N/A |
| Transport Information | N/A | Appearance | N/A |
| Safety | Poison by an unspecified route. Moderately toxic by intracerebral route. Human systemic effects by parenteral route: muscle spasms, blood pressure depression and musculo-skeletal changes. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of I− and NOx. | Risk Codes | N/A |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
N/A |
Iocarmate meglumine Chemical Properties
IUPAC Name: 3-[[6-[[3-Carboxy-2,4,6-triiodo-5-(methylcarbamoyl)phenyl]amino]-6-oxo-hexanoyl]amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid; (2R,3R,4R,5S)-6-methylaminohexane-1,2,3,4,5-pentol
Synonyms of Iocarmate meglumine (CAS NO.54605-45-7) : Bis(1-Deoxy-1-(methylammonio)-D-glucitol) 3,3'-(adipoyldiimino)bis(2,4,6-triiodo-5-(N-methylcarbamoyl)benzoate) ; bis[1-Deoxy-1-(methylammonio)-D-glucitol] 3,3'-(adipoyldiimino)bis[2,4,6-triiodo-5-(N-methylcarbamoyl)benzoate]
InChI:InChI=1/C24H20I6N4O8.2C7H17NO5/c1-31-21(37)9-13(25)11(23(39)40)17(29)19(15(9)27)33-7(35)5-3-4-6-8(36)34-20-16(28)10(22(38)32-2)14(26)12(18(20)30)24(41)42;2*1-8-2-4(10)6(12)7(13)5(11)3-9/h3-6H2,1-2H3,(H,31,37)(H,32,38)(H,33,35)(H,34,36)(H,39,40)(H,41,42);2*4-13H,2-3H2,1H3
CAS NO:54605-45-7
Molecular Formula:C38H54I6N6O18
Molecular Weight :1644.2916
Molecular Structure :.png)
EINECS: 259-252-7
Flash Point: 851.1 °C
Enthalpy of Vaporization: 238.89 kJ/mol
Boiling Point: 1483.7 °C at 760 mmHg
Vapour Pressure: 0 mmHg at 25°
Iocarmate meglumine Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intracrebral | 697mg/kg (697mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Kiso to Rinsho. Clinical Report. Vol. 8, Pg. 595, 1974. |
| mouse | LD50 | intravenous | 10900mg/kg (10900mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Kiso to Rinsho. Clinical Report. Vol. 8, Pg. 595, 1974. |
| mouse | LD50 | oral | > 16gm/kg (16000mg/kg) | GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Kiso to Rinsho. Clinical Report. Vol. 8, Pg. 595, 1974. |
| mouse | LD50 | subcutaneous | > 16gm/kg (16000mg/kg) | GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Kiso to Rinsho. Clinical Report. Vol. 8, Pg. 595, 1974. |
| rabbit | LD50 | unreported | 67600ug/kg (67.6mg/kg) | Journal of the American College of Toxicology. Vol. 9, Pg. 563, 1990. | |
| rat | LD50 | intracrebral | 610mg/kg (610mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Kiso to Rinsho. Clinical Report. Vol. 8, Pg. 595, 1974. |
| rat | LD50 | intravenous | 13300mg/kg (13300mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Kiso to Rinsho. Clinical Report. Vol. 8, Pg. 595, 1974. |
| rat | LD50 | oral | > 16gm/kg (16000mg/kg) | GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Kiso to Rinsho. Clinical Report. Vol. 8, Pg. 595, 1974. |
| rat | LD50 | subcutaneous | > 16gm/kg (16000mg/kg) | GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Kiso to Rinsho. Clinical Report. Vol. 8, Pg. 595, 1974. |
| rat | LD50 | unreported | 74100ug/kg (74.1mg/kg) | Journal of the American College of Toxicology. Vol. 9, Pg. 563, 1990. | |
| women | TDLo | parenteral | 140mg/kg (140mg/kg) | BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION MUSCULOSKELETAL: OTHER CHANGES | British Medical Journal. Vol. 1, Pg. 692, 1978. |
Iocarmate meglumine Safety Profile
Poison by an unspecified route. Iocarmate meglumine (CAS NO.54605-45-7) is moderately toxic by intracerebral route. Human systemic effects by parenteral route: muscle spasms, blood pressure depression and musculo-skeletal changes. An experimental teratogen. Experimental reproductive effects. When Iocarmate meglumine (CAS NO.54605-45-7) is heated to decomposition, it emits toxic fumes of I− and NOx.
What can I do for you?
Get Best Price
